Inspira (IINN) 6-K: New VP Global Sales & Board Member

Inspira Technologies Oxy B.H.N.

Rhea-AI Filing Summary

Inspira Technologies Oxy B.H.N. Ltd. (IINN) filed a Form 6-K announcing leadership additions. On October 21, 2025, the company furnished a press release titled “Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm.”

The first three paragraphs and the “Forward-Looking Statements” section of the release are incorporated by reference into Inspira’s Registration Statements on Forms F-3 and S-8, effective from the submission date, to the extent not superseded by later filings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IINN disclose in its Form 6-K?

IINN furnished a press release announcing a new VP of Global Sales and a new board member, dated October 21, 2025.

Which parts of the press release are incorporated by reference for IINN?

The first, second and third paragraphs and the “Forward-Looking Statements” section are incorporated by reference.

Which IINN registration statements are referenced in this 6-K?

Forms F-3 (Reg. Nos. 333-266748, 333-284308, 333-289324) and S-8 (Reg. Nos. 333-259057, 333-277980, 333-285565, 333-290162).

When was the press release issued by IINN?

The press release was issued on October 21, 2025.

What is the title of the IINN press release furnished with this 6-K?

“Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm.”

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/21/2025 - 03:40 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of October 2025 (Report No. 2)

Commission File Number: 001-40303

Inspira Technologies Oxy B.H.N. Ltd.

(Translation of registrant’s name into English)

2 Ha-Tidhar St.

Ra’anana 4366504, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F      ☐ Form 40-F

CONTENTS

On October 21, 2025, Inspira Technologies Oxy B.H.N. Ltd. (the “Company”) issued a press release titled “Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm,” a copy of which is furnished as Exhibit 99.1 with this report of foreign private issuer on Form 6-K.

The first, second and third paragraphs and the section titled “Forward-Looking Statements” in the press release are incorporated by reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-266748, 333-284308 and 333-289324) and Form S-8 (Registration Nos. 333-259057, 333-277980, 333-285565 and 333-290162), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

Exhibit No.
99.1		Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on October 21, 2025, titled “Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm.”

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Inspira Technologies Oxy B.H.N. Ltd.
Date: October 21, 2025	By:	/s/ Dagi Ben-Noon
		Name:	Dagi Ben-Noon
		Title:	Chief Executive Officer

2